Clear 10°. Wind: N 0 mph.
Trending: Trump selects new architect to oversee ballroom project, White House says
HomeNewsNationalHealth ( Page 3)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

WATCH: Pritzker encourages protests; Vaccine law signed; Chicago priorities criticized

(The Center Square) - In today's edition of Illinois in Focus Daily, The Center Square Editor Greg Bishop shares the continued debate around federal immigration enforcement and the state's migrant sanctuary policies with Gov. J.B. Pritzker encouraging protests against ICE. ...
by

Germany does not expect US-UK pharma deal to affect drug prices

BERLIN, Dec 3 (Reuters) - Germany's health ministry does not expect a pharmaceutical deal between the United States and Britain to have any impact on drug prices in the Germany or on statutory health insurance expenditures, said a spokesperson in Berlin on Wednesday. "This ...
by

Researchers slightly lower study’s estimate of drop in global income due to climate change

The authors of a study that examined climate change's potential effect on the global economy said Wednesday that data errors led them to slightly overstate an expected drop in income over the next 25 years. The researchers at Germany's Potsdam Institute for Climate Impact Research, ...
by

Health Rounds: Experimental drug shows promise for stroke patients who miss the current medical treatment window

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid Dec 3 (Reuters) - Stroke patients who can't get to the hospital quickly enough to be eligible for the usual clot-busting treatments may ...
by

Capricor’s muscle disorder cell therapy succeeds in late-stage study

Dec 3 (Reuters) - Capricor Therapeutics said on Wednesday its cell therapy for a heart condition related to a rare muscular disorder met the main goal of a late-stage study, months after U.S. regulators rejected its initial approval bid. The therapy, called deramiocel, slowed the ...
by

Excelsior Sciences raises $95 million to speed small molecule drug development using AI

By Kamal Choudhury Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial intelligence to accelerate the development and testing of small molecules, aiming to cut years off drug discovery timelines. The company ...
https://www.osfhealthcare.org/c/only-at-osf-w
by

Airline pilots hide mental health struggles to keep flying

By Rajesh Kumar Singh and Dan Catchpole SALT LAKE CITY, Utah, Dec 3 (Reuters) - Annie Vargas could see her son slipping away and pleaded with him to seek help. But her son, Brian Wittke, a 41-year-old Delta Air Lines pilot and father of three, ...
by

Anabel’s lost year illustrates the failings of Spain’s breast cancer program

By Elena Rodriguez SEVILLE, Spain, Dec 3 (Reuters) - Anabel Cano believed she was in the clear after receiving no follow-up for a breast cancer screening in 2023 at Seville's Virgen del Rocio Hospital. But a year later, during what she assumed was another routine ...
by

Doping at your doorstep: The next Olympic drug crisis could be coming through the mail

COLORADO SPRINGS, Colo. (AP) - The next Olympic doping scandal could be delivered right to your doorstep. A trove of so-called research chemicals known as peptides, many of them banned by the World Anti-Doping Agency and some not approved for human use in the United ...
by

UltraGreen.ai, a rare non-REIT listing for Singapore, jumps in market debut

By Yantoultra Ngui and Jun Yuan Yong SINGAPORE, Dec 3 (Reuters) - Singapore's UltraGreen.ai, a medical imaging company focused on fluorescence-guided surgery, surged 8% in its market debut on Wednesday after its IPO raised $400 million in the city-state's largest non-REIT offering in ...
by

WATCH: Chicago mayor, ‘responsible stewards’ defend taxes, opponents say they’ve failed

(The Center Square) - Mayor Brandon Johnson says he wants to make Chicago the safest and most affordable big city in the country, but Chicago Republicans say the city is not safe or affordable. ...
by

Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trials

By Deena Beasley SAN DIEGO Dec 2 (Reuters) - Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans, animals and real-world findings, a top company executive said on Tuesday, acknowledging criticism that Novo's ...
First Previous1234567Next Last